HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ingrid M Bistervels Selected Research
Ingrid M Bistervels Research Topics
Disease
6
Venous Thrombosis (Deep-Vein Thrombosis)
01/2023 - 01/2018
4
Venous Thromboembolism
11/2022 - 11/2018
4
Hemorrhage
01/2022 - 01/2019
3
Pulmonary Embolism
07/2021 - 11/2018
2
Postthrombotic Syndrome
07/2022 - 11/2018
1
Frailty
01/2022
1
Fetal Death
01/2022
1
Thrombosis (Thrombus)
01/2022
1
Wounds and Injuries (Trauma)
01/2022
1
Pregnancy Complications
01/2019
1
Thromboembolism
01/2019
1
Uterine Hemorrhage (Uterine Bleeding)
01/2019
1
Hemoptysis
01/2019
1
Pre-Eclampsia (Preeclampsia)
01/2019
1
Subacute Sclerosing Panencephalitis (SSPE)
11/2018
1
Venous Insufficiency
01/2018
Drug/Important Bio-Agent (IBA)
3
Anticoagulants
IBA
01/2022 - 01/2019
2
edoxaban
IBA
07/2022 - 07/2021
2
Warfarin (Coumadin)
FDA Link
Generic
07/2022 - 07/2021
2
Rivaroxaban
IBA
01/2022 - 01/2022
2
Vitamin K
FDA Link
01/2022 - 01/2022
2
fibrin fragment D (D-dimer)
IBA
01/2019 - 11/2018
1
cupric sulfide (CuS)
IBA
01/2023
1
Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
IBA
11/2022
1
Enoxaparin (Lovenox)
FDA Link
Generic
01/2022
1
Member 1 Subfamily B ATP Binding Cassette Transporter
IBA
01/2022
1
Cytochrome P-450 CYP3A
IBA
01/2022
1
Hemostatics (Antihemorrhagics)
IBA
01/2019
1
Tranexamic Acid (AMCA)
FDA Link
01/2019
1
4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acid
IBA
11/2018
Therapy/Procedure
3
Therapeutics
01/2019 - 01/2018
2
Polypharmacy
01/2022 - 01/2022
2
Duration of Therapy
11/2018 - 01/2018
1
Contraindications
01/2022
1
Vena Cava Filters (Inferior Vena Cava Filter)
01/2022
1
Compression Stockings
01/2018